Nanoparticle-Mediated Diagnostics and Drug Delivery Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 24 August 2024 | Viewed by 1968
Special Issue Editors
Interests: nanoparticles synthesis; drug delivery; tumor theranostics; nanoparticles assembly; nanocomposites
Interests: nanoparticles synthesis; polymers; nanomaterials; composites; antibacterial activity
Interests: polyelectrolytes; liposomes; interfacial complexes; drug delivery; nanocontainers; micelles; biocides
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Increasing the treatment efficiency of various dangerous diseases is among the most urgent tasks of modern medicine. The primary ways to solve the issue are to develop methods for the early diagnosis of diseases and to the performance of minimally invasive therapy (including by means of targeted delivery and controlled release of drugs). Such delivery can significantly reduce the risk of side effects and, as a result, increase the patient's quality of life.
The use of different nanoparticles as diagnostic tools or drug carriers is of significant interest from both scientific and practical points of view, as the distribution of such nanocarriers in the body can be controlled by varying their size and/or surface chemistry. In addition, they can serve not only in diagnosis or transport, but also as therapeutic agents, acting as sensitizers of one or another external influence (radiation, laser, ultrasonic, etc.). As a result, it becomes possible to combine different types of therapy.
This Special Issue aims to bring together reviews and experimental works reflecting the main trends, challenges and latest advances in the creation and practical usage of nanoparticles that are capable of serving as diagnostic and drug delivery tools.
Dr. Olga V. Dement'eva
Dr. Ivan N. Senchikhin
Dr. Andrey V. Sybachin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials for diseases theranostics
- nanomaterials for multimodal therapy
- nanomaterials for diagnostics
- stimuli responsive nanocarriers
- biodegradable nanocarriers
- the routes of drug nanocarriers’ administration
- active and passive targeting of nanocarriers
- nanocarriers biodistribution
- toxicity of nanocarriers
- delivery of hydrophobic drugs
- microemulsions as drug delivery systems
- drug encapsulation methods
- drug release models
